Are the new diagnoses needed in psychiatry, or is it enough for us to remember valentin magnan’s bouffée délirante? (To the article by E.V. Snedkov and co-authors ‘Is anti-NMDA receptor encephalitis real?’)
- Authors: Sivolap Y.P.1, Portnova A.A.1,2
-
Affiliations:
- RUDN University, Medical Institute
- The Serbsky State Scientific Center for Social and Forensic Psychiatry
- Issue: Vol LV, No 4 (2023)
- Pages: 89-95
- Section: Discussions
- URL: https://journals.rcsi.science/1027-4898/article/view/254025
- DOI: https://doi.org/10.17816/nb624840
- ID: 254025
Cite item
Abstract
New clinical observations and new scientific data lead to the identification of new diseases. Anti-NMDA receptor encephalitis, which mainly develops in young women due to ovarian teratoma and other suspected etiological factors, manifested by numerous neurological and psychiatric symptoms that give an acute condition resembling primary mental disorders, and accompanied by the appearance of antibodies to NMDA receptors, is one example of this kind. Some experts are questioning whether anti-NMDA receptor encephalitis should be considered a separate neuropsychiatric disorder. This article analyses a recent publication by one of the groups opposing the new diagnosis.
Full Text
##article.viewOnOriginalSite##About the authors
Yury P. Sivolap
RUDN University, Medical Institute
Author for correspondence.
Email: yura-sivolap@yandex.ru
ORCID iD: 0000-0002-4494-149X
SPIN-code: 3586-5225
M.D., D. Sci. (Med.), Prof.
Russian Federation, MoscowAnna A. Portnova
RUDN University, Medical Institute; The Serbsky State Scientific Center for Social and Forensic Psychiatry
Email: aapserbsky@mail.ru
ORCID iD: 0000-0001-5938-0202
SPIN-code: 5899-0069
M.D., D. Sci. (Med.)
Russian Federation, Moscow; MoscowReferences
- Schuck A, Calati R, Barzilay S et al. Suicide crisis syndrome: A review of supporting evidence for a new suicide-specific diagnosis. Behav Sci Law. 2019;37(3):223–239. doi: 10.1002/bsl.2397.
- Dalmau J, Armangué T, Planagumà J et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: Mechanisms and models. Lancet Neurol. 2019;18(11):1045–1057. doi: 10.1016/S1474-4422(19)30244-3.
- Bond TC. Recognition of acute delirious mania. Arch Gen Psychiatry. 1980;37(5):553–554.
- Cordeiro CR, Saraiva R, Côrte-Real B et al. When the bell rings: Clinical features of Bell’s mania. Prim Care Companion CNS Disord. 2020;22(2):19102511. doi: 10.4088/PCC.19l02511.
- Danivas V, Behere RV, Varambally V et al. Electroconvulsive therapy in the treatment of delirious mania: A report of 2 patients. J ECT. 2010;26(4):278–279. doi: 10.1097/yct.0b013e3181da848f.
- Ho JD, Smith SW, Nystrom PC et al. Successful management of excited delirium syndrome with prehospital ketamine: Two case examples. Prehosp Emerg Care. 2013;17(2):274–279. doi: 10.3109/10903127.2012.729129.
- Restrepo-Martinez M, Ramirez-Bermudez J, Bayliss L, Espinola-Nadurille M. Delirious mania as a frequent and recognizable neuropsychiatric syndrome in patients with anti-NMDAR encephalitis. Gen Hosp Psychiatry. 2020;64:50–55. doi: 10.1016/j.genhosppsych.2020.03.003.
![](/img/style/loading.gif)